These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32076434)

  • 1. Implementation of Pharmacogenetics in Primary Care: A Multi-Stakeholder Perspective.
    Rigter T; Jansen ME; de Groot JM; Janssen SWJ; Rodenburg W; Cornel MC
    Front Genet; 2020; 11():10. PubMed ID: 32076434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice.
    Martens FK; Huntjens DW; Rigter T; Bartels M; Bet PM; Cornel MC
    Front Pharmacol; 2019; 10():1609. PubMed ID: 32047438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stakeholder views on pharmacogenomic testing.
    Patel HN; Ursan ID; Zueger PM; Cavallari LH; Pickard AS
    Pharmacotherapy; 2014 Feb; 34(2):151-65. PubMed ID: 24167008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moving Pharmacogenetics Into Practice: It's All About the Evidence!
    Luzum JA; Petry N; Taylor AK; Van Driest SL; Dunnenberger HM; Cavallari LH
    Clin Pharmacol Ther; 2021 Sep; 110(3):649-661. PubMed ID: 34101169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardizing terms for clinical pharmacogenetic test results: consensus terms from the Clinical Pharmacogenetics Implementation Consortium (CPIC).
    Caudle KE; Dunnenberger HM; Freimuth RR; Peterson JF; Burlison JD; Whirl-Carrillo M; Scott SA; Rehm HL; Williams MS; Klein TE; Relling MV; Hoffman JM
    Genet Med; 2017 Feb; 19(2):215-223. PubMed ID: 27441996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preemptive pharmacogenetic testing: exploring the knowledge and perspectives of US payers.
    Keeling NJ; Rosenthal MM; West-Strum D; Patel AS; Haidar CE; Hoffman JM
    Genet Med; 2019 May; 21(5):1224-1232. PubMed ID: 31048813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward Integration of mHealth in Primary Care in the Netherlands: A Qualitative Analysis of Stakeholder Perspectives.
    Bally ELS; Cesuroglu T
    Front Public Health; 2019; 7():407. PubMed ID: 32010660
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

  • 11. Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
    Lee YM; Manzoor BS; Cavallari LH; Nutescu EA
    Pharmacotherapy; 2018 Feb; 38(2):205-216. PubMed ID: 29286540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to Implement a Pharmacogenetics Service at your Institution.
    Cicali EJ; Lemke L; Al Alshaykh H; Nguyen K; Cavallari LH; Wiisanen K
    J Am Coll Clin Pharm; 2022 Nov; 5(11):1161-1175. PubMed ID: 36589694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perspectives of Pediatric Providers Regarding Clinical Use of Pharmacogenetics.
    Avello K; Bell M; Stein Q; Bares V; Landsverk M; Salyakina D; McCafferty-Fernandez J; Kingsmore S; Bedrick A; Bhojwani D; Hoyme HE
    S D Med; 2021 Jul; 74(7):294-301. PubMed ID: 34449988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 360-degree Delphi: addressing sociotechnical challenges of healthcare IT.
    Waldmüller H; Spreckelsen C; Rudat H; Krumm N; Rolke R; Jonas SM
    BMC Med Inform Decis Mak; 2020 Jun; 20(1):101. PubMed ID: 32503609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying Barriers to Implementation of the National Partnership for Maternal Safety Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method.
    De Tina A; Chau A; Carusi DA; Robinson JN; Tsen LC; Farber MK
    Anesth Analg; 2019 Oct; 124(9):1045-1050. PubMed ID: 29787407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multilevel stakeholder approach for identifying the determinants of implementation of government-funded community pharmacy services at the primary care level.
    Hossain LN; Tudball J; Franco-Trigo L; Durks D; Benrimoj SI; Sabater-Hernández D
    Res Social Adm Pharm; 2018 Aug; 14(8):765-775. PubMed ID: 29033347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mapping the route to medication therapy management documentation and billing standardization and interoperabilility within the health care system: meeting proceedings.
    Millonig MK
    J Am Pharm Assoc (2003); 2009; 49(3):372-82. PubMed ID: 19357067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivering an iterative Communication Partner Training programme to multidisciplinary healthcare professionals: A pilot implementation study and process evaluation.
    Shrubsole K; Lin TJ; Burton C; Scott J; Finch E
    Int J Lang Commun Disord; 2021 May; 56(3):620-636. PubMed ID: 33818902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.